Zveik O - Search Results

1

Severe Acute Respiratory Syndrome Coronavirus 2 Third Vaccine Immune Response in Multiple Sclerosis Patients Treated with Ocrelizumab.

Brill L, Raposo C, Rechtman A, Zveik O, Levin N, Oiknine-Djian E, Wolf DG, Vaknin-Dembinsky A. Brill L, et al. Among authors: zveik o. Ann Neurol. 2022 Jun;91(6):796-800. doi: 10.1002/ana.26343. Epub 2022 Mar 24. Ann Neurol. 2022. PMID: 35243687 Free PMC article.

2

Humoral and T-Cell Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Ocrelizumab.

Brill L, Rechtman A, Zveik O, Haham N, Oiknine-Djian E, Wolf DG, Levin N, Raposo C, Vaknin-Dembinsky A. Brill L, et al. Among authors: zveik o. JAMA Neurol. 2021 Dec 1;78(12):1510-1514. doi: 10.1001/jamaneurol.2021.3599. JAMA Neurol. 2021. PMID: 34554197 Free PMC article.

3

Effect of cladribine on COVID-19 serology responses following two doses of the BNT162b2 mRNA vaccine in patients with multiple sclerosis.

Brill L, Rechtman A, Zveik O, Haham N, Levin N, Shifrin A, Rozenberg A, Vaknin-Dembinsky A. Brill L, et al. Among authors: zveik o. Mult Scler Relat Disord. 2022 Jan;57:103343. doi: 10.1016/j.msard.2021.103343. Epub 2021 Oct 23. Mult Scler Relat Disord. 2022. PMID: 35158452 Free PMC article.

4

Longitudinal humoral response in MS patients treated with cladribine tablets after receiving the second and third doses of SARS-CoV-2 mRNA vaccine.

Brill L, Rechtman A, Shifrin A, Rozenberg A, Afanasiev S, Zveik O, Haham N, Levin N, Vaknin-Dembinsky A. Brill L, et al. Among authors: zveik o. Mult Scler Relat Disord. 2022 Jul;63:103863. doi: 10.1016/j.msard.2022.103863. Epub 2022 May 10. Mult Scler Relat Disord. 2022. PMID: 35667316 Free PMC article.

5

Brain MRI activity during the year before pregnancy can predict post-partum clinical relapses.

Lehmann H, Zveik O, Levin N, Brill L, Imbar T, Vaknin-Dembinsky A. Lehmann H, et al. Among authors: zveik o. Mult Scler. 2021 Dec;27(14):2232-2239. doi: 10.1177/13524585211002719. Epub 2021 Mar 30. Mult Scler. 2021. PMID: 33783260

6

Cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cells.

Zveik O, Fainstein N, Rechtman A, Haham N, Ganz T, Lavon I, Brill L, Vaknin-Dembinsky A. Zveik O, et al. Glia. 2022 Jun;70(6):1191-1209. doi: 10.1002/glia.24165. Epub 2022 Mar 9. Glia. 2022. PMID: 35266197 Free PMC article.

7

Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course.

Rechtman A, Brill L, Zveik O, Uliel B, Haham N, Bick AS, Levin N, Vaknin-Dembinsky A. Rechtman A, et al. Among authors: zveik o. Front Neurol. 2022 Mar 24;13:867190. doi: 10.3389/fneur.2022.867190. eCollection 2022. Front Neurol. 2022. PMID: 35401390 Free PMC article.

8

Sera of Neuromyelitis Optica Patients Increase BID-Mediated Apoptosis in Astrocytes.

Zveik O, Rechtman A, Haham N, Adini I, Canello T, Lavon I, Brill L, Vaknin-Dembinsky A. Zveik O, et al. Int J Mol Sci. 2022 Jun 27;23(13):7117. doi: 10.3390/ijms23137117. Int J Mol Sci. 2022. PMID: 35806122 Free PMC article.

9

IL-6 as a marker for NMOSD disease activity.

Haramati A, Rechtman A, Zveik O, Haham N, Brill L, Vaknin-Dembinsky A. Haramati A, et al. Among authors: zveik o. J Neuroimmunol. 2022 Sep 15;370:577925. doi: 10.1016/j.jneuroim.2022.577925. Epub 2022 Jul 2. J Neuroimmunol. 2022. PMID: 35810527

10

MIF -173G/C polymorphism is associated with NMO disease severity.

Brill L, Vaknin-Dembinsky A, Zveik O, Haham N, Miller K, Benedek G. Brill L, et al. Among authors: zveik o. J Neuroimmunol. 2020 Feb 15;339:577120. doi: 10.1016/j.jneuroim.2019.577120. Epub 2019 Nov 25. J Neuroimmunol. 2020. PMID: 31790982

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters